Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Action item for AB

Action item for AB

posted on Nov 07, 2005 05:15AM
Perhaps the AB could recommend that a company goal be something like:

In the interest of proper corporate governance and in order to insure a diverse and proactive BOD, it shall be the policy of this company that no 2 directors share an affiliation with an entity that directly or indirectly controls shares (warrants, debentures) that represent 10% of the company.

The lawyers could clean up the language a bit, but I think you get my drift. This could be placed before the board at the next meeting and voted on by the shareholders at the next SHM. Which, if the company holds true to form on its 18 month cycle, will be sometime in the fall of 2006.

Share
New Message
Please login to post a reply